Table 4.
Disease-free survival analyses according to LMR change in 674 patients with ESCC.
| Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | |
| NLRc | 1.013 | 0.976-1.060 | 0.591 | |||
| LMRc | 0.677 | 0.507-0.905 | 0.008 | 0.640 | 0.476-0.859 | 0.003 |
| PLRc | 1.000 | 0.998-1.001 | 0.617 | |||
| Sex | 1.210 | 0.788-1.858 | 0.383 | |||
| Age (years) | 0.992 | 0.973-1.010 | 0.376 | |||
| Pathology grade | 1.652 | 1.264-2.157 | <0.001 | 1.515 | 1.140-2.014 | 0.004 |
| Depth of tumor | 1.144 | 0.902-1.450 | 0.266 | |||
| Lymph node metastasis | 1.598 | 1.377-1.853 | <0.001 | 1.534 | 1.222-1.926 | <0.001 |
| Pathological stage | 1.558 | 1.257-1.932 | <0.001 | 0.824 | 0.595-1.140 | 0.242 |
| Vessel invasive | 1.292 | 0.949-1.760 | 0.104 | |||
| Nerve infiltration | 1.623 | 1.213-2.170 | 0.001 | 1.580 | 1.160-2.150 | 0.004 |
| Treatment regimen | 1.385 | 1.233-1.556 | <0.001 | 1.284 | 1.133-1.45 | <0.001 |
| Hospital time (days) | 1.000 | 0.989-1.012 | 0.975 | |||